First in Patient Study of Anti-GM-CSF Monoclonal Antibody (MOR103) in Active Rheumatoid Arthritis: Results of a Phase 1b/2a Randomized, Double-Blind, Placebo-Controlled Trial
Author(s):
Behrens, F.; Ostergaard, M.; Stoilov, R.; Wiland, P.; Huizinga, T.W.; Berenfus, V.Y.; Tak, P.P.; Vladeva, S.; Rech, J.; Rubbert-Roth, A.; Korkosz, M.; Rekalov, D.; Zupanets, I.A.; Ejbjerg, B.J.; Geiseler, J.; Fresenius, J.; Korolkiewicz, R.P.; Schottelius, A.J.; Burkhardt, H.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-12-31
Language
English
Is part of
Arthritis and Rheumatism (2012), Vol. 64, no. 12, p. 4171-4172
